Research Reports

Healthcare

icon
Home » Reports » Peptide Therapeutics Market Global Market Size Demand Analysis Opportunity Outlook 2023
Market Research Report

Peptide Therapeutics Market | Global Market Size, Demand Analysis & Opportunity Outlook 2023

Published On : 05:52 AM, 23rd April, 2018 REP-ID-180 Category: Healthcare

Global Peptide Therapeutics Market Overview

Therapeutic peptides have established importance in the treatment of numerous diseases such as nervous system disorders, gastrointestinal disorders, prostrate, breast and ovarian cancers. Peptides carrying antagonists and agonists receptors in nature are progressively being tested for their effectiveness in cancer treatment.

Introduction of advanced cost effective therapeutic peptides, rising clinical drug researches in order to treat cancers and other disorders, increases safety and effectiveness of therapeutic peptide, thus swelling the demand for peptide therapeutic globally.

                           Peptide Therapeutics Market Demand & Revenue

Market size and forecast

The global peptide therapeutic market is predicted to flourish significantly at a CAGR of 8.2% over the forecast period i.e. 2016-2023. Moreover, the market of peptide therapeutic market accounted for USD 15.6 Billion in 2015 and the market is further anticipated to garner USD 26.2 Billion by 2023. North America accounted for USD 7.42 Billion in 2015 in peptide therapeutic market across the globe. The market of North America region is expected to continue its dominance over the forecast period and predicted to register a CAGR of 6.9% over the forecast period i.e. 2016-2023 owing to intensification of pharmaceutical and biotech companies across the region. On the other hand, Europe is expected to be the second largest share contributor across the globe in the market of peptide therapeutics due to presence of large number of biotech companies across the region and increase in healthcare expenditure. Moreover, the market of Asia-Pacific market of peptide therapeutic is estimated to grow significantly over the forecast period. Rising biotech companies and increasing healthcare spending by the government authorities, rising prevalence of cancer and nervous system disorders are some of the factors prompting the demand for peptide therapeutics in near future.

Rapid growth in therapeutic drugs owing to increasing investments in research and development aims to increase efficacy of therapeutic peptides and absence of toxicity which helps the drug industry to develop efficient therapeutic drugs with less-side effects.  

Rising awareness towards peptide therapeutics and introduction of favorable re-imbursement policies by the government organizations across the globe are likely to shift the consumer and physicians to offer cost effective therapeutic peptides in order to adopt advanced drugs for treatment of severe disorders.

The diseases such as brain disorders and cancers are increasing burden which leads to increase healthcare expenditure. The nations facing economic issues are likely to adopt cost effective and efficient peptide therapeutic in order to minimize the burden in terms of economic cost and decrease the health expenditure.

Emergence of pharmaceutical and biotech companies, huge investment in healthcare startups and rising initiatives from government authorities to develop cost effective and safe drugs in order to minimize the disease burden in terms of human suffering are some of the factors exhibit the positive growth of peptide therapeutics in near future.

Demand Analysis By Market Segmentation:

Our in-depth analysis segmented the global peptide therapeutic market in the following segments:

By Application

Cancer

  • Zoladex (goserelin)
  • Velcade (bortezomib)
  • Lupron/ Enantone/ Eligard (leuprorelin)
  • Others

Cardiovascular

  • Angiomax (bivalirudin)
  • Integrilin (eptifibatide)

Central Nervous System

  • Copaxone (glatiramer)

Metabolic Disorders

  • Victoza (liraglutide)
  • Byetta (exenatide)
  • Others

Infection

  • Incivek (telaprevir)
  • Victrelis (boceprevir)

Hematological Disorders

  • Firazyr (icatibant)
  • Kalbitor (ecallantide)

Gastrointestinal Disorders

  • Gattex (teduglutide)
  • Linzess (linaclotide)

Respiratory Disorders

Acromegaly

Other Applications

By Route of Administration

  • Parenteral
  • Oral
  • Pulmonary
  • Mucosal

By Drugs Type

  • Branded
  • Generic

By End-User

  • Research Laboratories
  • Pharmaceutical Industries
  • Hospitals

By Region

Global peptide therapeutic market is further classified on the basis of region as follows:

  • North America (United States /U.S. & Canada)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Western and Eastern Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Western Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia)
  • Middle East and North Africa (MENA)
  • Rest of World

Growth Drivers and challenges

Increase in aging population is predicted to trigger the prevalence of diseases such as cardiac, cardiovascular and osteoporosis, further increasing the burden on emerging economies across the globe, thus intensifying the demand for peptide therapeutics so as to reduce the burden and minimize the health expenditure.

In addition to this, factors such as introduction of cost-effective and efficient peptide therapeutics, availability of miscellaneous peptide therapeutics for treatment of several disorders, rising preferences by physicians towards peptide therapeutics and increasing demand in research laboratories to deliver more effective drugs for the treatment of cancers are some of the key elements expected to prompt the demand for peptide therapeutics over the forecast period i.e. 2016-2023.

Moreover, the market of Asia-Pacific market of peptide therapeutic is estimated to grow significantly over the forecast period. Rising biotech companies and increasing healthcare spending by the government authorities, rising prevalence of cancer and nervous system disorders are some of the factors expected to fuel the demand for peptide therapeutics in near future.

However, increasing cost of commercialization of peptide therapeutics, presence of stringent regulatory controls for peptide therapeutics, unfavorable physiological conditions such as presence of several reactive enzymes, huge expenditure needed in research and development are some of the factors likely to inhibit the growth of peptide therapeutics market in near future.

Key Players

The key vendors of peptide therapeutic market are as follows:

  • Bachem Holding AG
    • Company Overview
    • Key Product Offerings
    • Business Strategy
    • SWOT Analysis
    • Financials
  • CordenPharma International GmbH
  • Eli Lilly and Company
  • Ipsen S.A.
  • Merck & Co.
  • Novo Nordisk A/S
  • PolyPeptide Group

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

The Global Peptide Therapeutic Market is segmented as follows:

  • By Application type Market Size and Y-O-Y Growth Analysis
  • By Route of Administration Market Size and Y-O-Y Growth Analysis
  • By Drugs type Market Size and Y-O-Y Growth Analysis
  • By End-user Market Size and Y-O-Y Growth Analysis

By Regions

  • North America (United States/U.S., Canada) Market Size and Y-O-Y Growth Analysis
  • Latin America (Mexico, Brazil, Rest of Latin America) Market Size and Y-O-Y Growth Analysis
  • Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe) Market Size and Y-O-Y Growth Analysis
  • Asia-Pacific (China, India, Singapore, Japan, Australia and New Zealand and Rest of Asia) Market Size and Y-O-Y Growth Analysis
  • Middle East and North Africa (MENA) Market Size and Y-O-Y Growth Analysis
  • Rest of World  Market Size and Y-O-Y Growth Analysis

Market Dynamics

Supply and Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

 

                 Key Answers Captured in Report?

Which geography would have better demand for product/services?
What are the strategies adopted by big players in the regional market?
Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth?
What is the current & expected market size in next five years?
What is the market feasibility for long term investment?
What opportunity the country would offer for existing and new players in the market?
What is risk involved for suppliers in the geography?
What factors would drive the demand for the product/service in near future?
What is the impact analysis of various factors in the market growth?
What are the recent trends in the regional market and how successful they are?

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com


UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Subscribe To Our Newsletters

Copyright © 2018 Research Nester. All rights reserved

Top